Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury

Background: We evaluated the efficacy of botulinum-A toxin (BTX-A) injection into detrusor muscle in patients with incontinence resistant to anticholinergic drugs due to detrusor overactivity.Methods: Our prospective study included 12 male patients with detrusor overactivity and incontinence due to...

Full description

Bibliographic Details
Main Authors: Gooran SH., Meysame A., Aghamir S.M.K., Mohseni M.GH, Mohtaram S.N.
Format: Article
Language:fas
Published: Tehran University of Medical Sciences 2008-03-01
Series:Tehran University Medical Journal
Subjects:
Online Access:http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5270.pdf&manuscript_id=5270
_version_ 1818969166619607040
author Gooran SH.
Meysame A.
Aghamir S.M.K.
Mohseni M.GH
Mohtaram S.N.
author_facet Gooran SH.
Meysame A.
Aghamir S.M.K.
Mohseni M.GH
Mohtaram S.N.
author_sort Gooran SH.
collection DOAJ
description Background: We evaluated the efficacy of botulinum-A toxin (BTX-A) injection into detrusor muscle in patients with incontinence resistant to anticholinergic drugs due to detrusor overactivity.Methods: Our prospective study included 12 male patients with detrusor overactivity and incontinence due to spinal cord injury, which had been unsuccessfully treated with anticholinergic medication. Under visual control through the cystoscope 300 units of BTX-A were injected into detrusor muscle at 30 sites, sparing the trigone. After the treatment patients continued to perform clean intermittent self-catheterization (CIC) and clinical follow-up was planned for 6 weeks, 6 months and 9 months after treatment and urodynamic study was repeated after 6 weeks.Results: At the 6-week follow-up complete continence was restored in  9 of the 12 patients and after 6 months of 9 continent patients 1 patient lost his follow-up  from the study and 7 were still continent. After 9 months 3 patients remained continent. Mean cystometric bladder capacity (p<0.001), compliance (p<0.001), and mean post-void residual urine volume significantly increased (p<0.001), whereas maximal detrusor contraction pressure significantly decreased (p<0.001).Conclusions: BTX-A injections appears to be an effective and safe therapeutic option for overactive bladder in adult patients with spinal cord injury failing anticholinergic therapy even if these patients present with very low bladder compliance. Patients may require repeated injections after 6 months to remain continent.
first_indexed 2024-12-20T14:16:16Z
format Article
id doaj.art-2a9698d9db744bde8781b156fbf462a2
institution Directory Open Access Journal
issn 1683-1764
1735-7322
language fas
last_indexed 2024-12-20T14:16:16Z
publishDate 2008-03-01
publisher Tehran University of Medical Sciences
record_format Article
series Tehran University Medical Journal
spelling doaj.art-2a9698d9db744bde8781b156fbf462a22022-12-21T19:38:01ZfasTehran University of Medical SciencesTehran University Medical Journal1683-17641735-73222008-03-0165105560Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injuryGooran SH.Meysame A.Aghamir S.M.K.Mohseni M.GHMohtaram S.N.Background: We evaluated the efficacy of botulinum-A toxin (BTX-A) injection into detrusor muscle in patients with incontinence resistant to anticholinergic drugs due to detrusor overactivity.Methods: Our prospective study included 12 male patients with detrusor overactivity and incontinence due to spinal cord injury, which had been unsuccessfully treated with anticholinergic medication. Under visual control through the cystoscope 300 units of BTX-A were injected into detrusor muscle at 30 sites, sparing the trigone. After the treatment patients continued to perform clean intermittent self-catheterization (CIC) and clinical follow-up was planned for 6 weeks, 6 months and 9 months after treatment and urodynamic study was repeated after 6 weeks.Results: At the 6-week follow-up complete continence was restored in  9 of the 12 patients and after 6 months of 9 continent patients 1 patient lost his follow-up  from the study and 7 were still continent. After 9 months 3 patients remained continent. Mean cystometric bladder capacity (p<0.001), compliance (p<0.001), and mean post-void residual urine volume significantly increased (p<0.001), whereas maximal detrusor contraction pressure significantly decreased (p<0.001).Conclusions: BTX-A injections appears to be an effective and safe therapeutic option for overactive bladder in adult patients with spinal cord injury failing anticholinergic therapy even if these patients present with very low bladder compliance. Patients may require repeated injections after 6 months to remain continent.http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5270.pdf&manuscript_id=5270Bladderoveractivespinal cord injuries
spellingShingle Gooran SH.
Meysame A.
Aghamir S.M.K.
Mohseni M.GH
Mohtaram S.N.
Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
Tehran University Medical Journal
Bladder
overactive
spinal cord injuries
title Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
title_full Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
title_fullStr Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
title_full_unstemmed Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
title_short Botulinum-A toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
title_sort botulinum a toxin in the treatment of urinary incontinence due to overactive bladder following spinal cord injury
topic Bladder
overactive
spinal cord injuries
url http://journals.tums.ac.ir/PdfMed.aspx?pdf_med=/upload_files/pdf/5270.pdf&manuscript_id=5270
work_keys_str_mv AT gooransh botulinumatoxininthetreatmentofurinaryincontinenceduetooveractivebladderfollowingspinalcordinjury
AT meysamea botulinumatoxininthetreatmentofurinaryincontinenceduetooveractivebladderfollowingspinalcordinjury
AT aghamirsmk botulinumatoxininthetreatmentofurinaryincontinenceduetooveractivebladderfollowingspinalcordinjury
AT mohsenimgh botulinumatoxininthetreatmentofurinaryincontinenceduetooveractivebladderfollowingspinalcordinjury
AT mohtaramsn botulinumatoxininthetreatmentofurinaryincontinenceduetooveractivebladderfollowingspinalcordinjury